Neothetics is a San Diego based clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. Our objective is to build a leading aesthetics company grounded in innovation. We are focused on development and commercialization of high value medical aesthetic products. Our strategy is maximizing the value of LIPO-202, our injectable drug for subcutaneous fat reduction or body contouring and our current focus is on submental region for double chin.